Literature DB >> 17559093

Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain.

Shigeyuki Yamamoto1, Hirotaka Onoe, Hideo Tsukada, Yasuyoshi Watanabe.   

Abstract

Using a combination of positron emission tomography (PET) and the microdialysis technique, the effects of increased endogenous serotonin (5-hydroxytryptamine; 5-HT) on the binding of [(11)C]DASB to 5-HT transporters (5-HTT) were investigated in the conscious monkey brain. Five rhesus monkeys (Macaca mulatta) were scanned with [(11)C]DASB under the control condition and the increased endogenous 5-HT condition, in which 5-hydroxy-L-tryptophan (5-HTP) was administered (20 mg/kg, i.v.) before the PET scan. Compared with the control scan, the 5-HTP administration significantly decreased the binding potential (BP) (BP = B(max)/K(d)) of [(11)C]DASB in several brain regions. The mean % decrease of BP was biggest in the caudate and putamen. Two monkeys were scanned with [(11)C]5-HTP to assess the amino acid decarboxylase (AADC) activity in the brain, resulting in the high activity in the caudate and putamen. Microdialysis measurements showed that although 5-HTP administration (20 mg/kg, i.v.) increased the extracellular 5-HT levels in both the prefrontal cortex and caudate, the increase of the 5-HT level in the caudate was 27 times higher than that in the prefrontal cortex. These results suggest that the caudate and putamen, both of which show high AADC activity, convert 5-HTP to 5-HT at a high rate, and the increased 5-HT competes with [(11)C]DASB for the 5-HTT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559093     DOI: 10.1002/syn.20422

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  11 in total

1.  Serotonin transporter binding after recovery from bulimia nervosa.

Authors:  Rama Pichika; Monte S Buchsbaum; Ursula Bailer; Carl Hoh; Alex Decastro; Bradley R Buchsbaum; Walter Kaye
Journal:  Int J Eat Disord       Date:  2011-06-13       Impact factor: 4.861

2.  Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.

Authors:  Shigeyuki Yamamoto; Hiroyuki Ohba; Shingo Nishiyama; Norihiro Harada; Takeharu Kakiuchi; Hideo Tsukada; Edward F Domino
Journal:  Neuropsychopharmacology       Date:  2013-07-24       Impact factor: 7.853

Review 3.  Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Authors:  Louise M Paterson; Robin J Tyacke; David J Nutt; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

4.  Behavioral and neurobiological characteristics influencing social hierarchy formation in female cynomolgus monkeys.

Authors:  N V Riddick; P W Czoty; H D Gage; J R Kaplan; S H Nader; M Icenhower; P J Pierre; A Bennett; P K Garg; S Garg; M A Nader
Journal:  Neuroscience       Date:  2008-11-17       Impact factor: 3.590

Review 5.  Application of cross-species PET imaging to assess neurotransmitter release in brain.

Authors:  Sjoerd J Finnema; Mika Scheinin; Mohammed Shahid; Jussi Lehto; Edilio Borroni; Benny Bang-Andersen; Jukka Sallinen; Erik Wong; Lars Farde; Christer Halldin; Sarah Grimwood
Journal:  Psychopharmacology (Berl)       Date:  2015-04-30       Impact factor: 4.530

6.  Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography.

Authors:  Marie Spies; Gregory M James; Neydher Berroterán-Infante; Harald Ibeschitz; Georg S Kranz; Jakob Unterholzner; Mathis Godbersen; Gregor Gryglewski; Marius Hienert; Johannes Jungwirth; Verena Pichler; Birgit Reiter; Leo Silberbauer; Dietmar Winkler; Markus Mitterhauser; Thomas Stimpfl; Marcus Hacker; Siegfried Kasper; Rupert Lanzenberger
Journal:  Int J Neuropsychopharmacol       Date:  2018-02-01       Impact factor: 5.176

7.  Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C]DASB.

Authors:  Jeong-Hee Kim; Young-Don Son; Hang-Keun Kim; Jong-Hoon Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2021-10-21       Impact factor: 2.570

8.  Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C]DASB Positron Emission Tomography Study.

Authors:  Marenka Smit; David Vállez García; Bauke M de Jong; Evelien Zoons; Jan Booij; Rudi A Dierckx; Antoon T Willemsen; Erik F de Vries; Anna L Bartels; Marina A Tijssen
Journal:  Front Neurol       Date:  2018-02-28       Impact factor: 4.003

9.  Serotonin concentration enhancers at clinically relevant doses reduce [11C]AZ10419369 binding to the 5-HT1B receptors in the nonhuman primate brain.

Authors:  Kai-Chun Yang; Akihiro Takano; Christer Halldin; Lars Farde; Sjoerd J Finnema
Journal:  Transl Psychiatry       Date:  2018-07-16       Impact factor: 6.222

10.  Serotonin transporter availability in adults with autism-a positron emission tomography study.

Authors:  Jacqueline Borg; Johan Lundberg; Max Andersson; Ämma Tangen; Lars Farde; Sven Bölte; Christer Halldin
Journal:  Mol Psychiatry       Date:  2020-08-26       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.